JP2005145945A - Skin function-activating cosmetic composition - Google Patents

Skin function-activating cosmetic composition Download PDF

Info

Publication number
JP2005145945A
JP2005145945A JP2003418679A JP2003418679A JP2005145945A JP 2005145945 A JP2005145945 A JP 2005145945A JP 2003418679 A JP2003418679 A JP 2003418679A JP 2003418679 A JP2003418679 A JP 2003418679A JP 2005145945 A JP2005145945 A JP 2005145945A
Authority
JP
Japan
Prior art keywords
skin
cosmetic composition
skin function
activating
fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003418679A
Other languages
Japanese (ja)
Inventor
Ichiro Kono
一郎 河野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAHITI AMBITION KK
Original Assignee
TAHITI AMBITION KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAHITI AMBITION KK filed Critical TAHITI AMBITION KK
Priority to JP2003418679A priority Critical patent/JP2005145945A/en
Publication of JP2005145945A publication Critical patent/JP2005145945A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To use the fruit components of Morinda citrifolia as a skin function-activating cosmetic composition and also reduce its strange smell which becomes an obstacle against its practical use and further to make sure of the development of its effect. <P>SOLUTION: The subject cosmetic composition is provided by maturing the fruits of M. citrifolia and using a sufficiently fermented filtrate as the skin function-activating cosmetic composition. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は皮膚機能劣化のあらわれであるこじわやしみ、皮膚弾力性の低下を、表皮の過角化や、チロシナーゼ、コラゲナーゼなどを抑制して改善しうる皮膚機能賦活化粧料組成物に関するものである。The present invention relates to a skin function-activating cosmetic composition capable of improving the occurrence of skin function deterioration, such as wrinkles and blemishes and skin elasticity, by suppressing hyperkeratosis of the epidermis, tyrosinase, collagenase and the like. is there.

近年わが国における化粧料品質は、組成物純度の向上や製造技術の進歩などによりすぐれたものになってきた。しかしその適用対象である皮膚や頭皮頭髪の機能劣化もまた急なものがあり、安全性たかく効果のすぐれた皮膚機能賦活化粧料やその構成組成物の要求度は、旧倍してたかくなっている。皮膚機能の劣化は直接的には紫外線刺激に起因するものの、劣化の加速は、内分泌バランスの乱れや増加するストレスによることが多く、その意味でその増悪要因である環境ホルモンによる汚染増や生活の近代化傾向の急進は、皮膚機能賦活努力の必要をさらにたかめることを求めている。因みに生活の近代化傾向は日常生活における栄養の向上(皮膚機能に障る活性酸素増)、生活時間での明時間の長さ、生活時間での他との(とくに雄性との)接触機会増(ホルモンバランスの乱れを招く)を指す。(〜「老化とホルモン」川島誠一郎著、東大出版会、より)。In recent years, the quality of cosmetics in Japan has become excellent due to improvements in composition purity and advances in manufacturing technology. However, there is also a sudden deterioration in the function of the target skin and scalp and hair, and the demand for safe and effective skin function activating cosmetics and their constituent compositions has increased compared to the previous level. Yes. Although skin function deterioration is directly caused by UV stimulation, acceleration of deterioration is often due to disturbance of endocrine balance or increasing stress. The rapid trend toward modernization calls for further increasing the need for skin function activation efforts. By the way, the trend of modernization of life is the improvement of nutrition in daily life (increased active oxygen that impedes skin function), the length of light time in life time, and the chance of contact with others in life time (especially with males) ( (This leads to disruption of hormone balance). (~ "Aging and hormones" by Seiichiro Kawashima, The University of Tokyo Press).

従来技術において、皮膚機能劣化を抑えるべく、少なからぬ化粧料組成物が、化粧料への配合を試みられているが、何れも有効性、安全性を具備すべきという用件をみたすに至っていない。例えば、チロシナーゼ抑制機能評価のもっともたかいハイドロキノンやコウジ酸の色素沈着への臨床報告では、ハイドロキノン7%軟膏やコウジ酸4%軟膏の使用において「それぞれ単独では長期の治療が必要な上、色素沈着の消退は不完全であった」とされる一方、副作用(使用者判定)は、それぞれ25%と7.7%にのぼる如きである。(NTT西日本大阪病院、「医薬ジャーナル」VOL37、NO.2)In the prior art, a number of cosmetic compositions have been tried to be incorporated into cosmetics in order to suppress deterioration of skin function, but none of them has yet reached the requirement that it should be effective and safe. . For example, in the clinical report on the hydroquinone and kojic acid pigmentation, which is the most effective in evaluating tyrosinase inhibitory function, in the use of hydroquinone 7% ointment and kojic acid 4% ointment, “each alone requires long-term treatment, and While the withdrawal was incomplete, side effects (user judgment) were 25% and 7.7%, respectively. (NTT West Osaka Hospital, “Pharmaceutical Journal” VOL37, NO.2)

この皮膚状態改善策として提案されたもののうちに、ヤエヤマアオキ果実抽出物または圧搾物または粉砕物があるが、これら物質には何れも悪臭ともいえる特異臭があり、その化粧料組成物としての応用は、化粧料の具備すべき官能性を著しく損ね、使用者本人、または使用者周囲に不快感をおぼえさせることから効果を生む実用に至っていない。
特開2001−199871号公報 特開2001−213733号公報 特開2001−213752号公報 特開2001−213753号公報 特開2001−213755号公報 特開2001−213758号公報 特開2002−121112号公報
Among those proposed as measures for improving the skin condition, there is a Yaeyama Aoki fruit extract or a pressed product or a pulverized product, but these substances all have a peculiar odor that can be called a bad odor, and its application as a cosmetic composition is However, it has not yet been put into practical use, since it greatly impairs the functionality that cosmetics should have and makes the user himself or herself feel uncomfortable.
JP 2001-199871 A JP 2001-213733 A JP 2001-213752 A JP 2001-213753 A JP 2001-213755 A JP 2001-213758 A JP 2002-121112 A

解決しようとする課題は、皮膚機能賦活化粧料組成物としてヤエヤマアオキ果実成分を用いる上で実用の障りになる異臭的原料臭を減じ、なお効果発現を確かにする点にある。  The problem to be solved is to reduce the off-flavor raw material odor that impedes the practical use of the Yaeyama Aoki fruit component as a skin function activating cosmetic composition, and to ensure the effect.

本発明はヤエヤマアオキ果実を熟成させさらに十分発酵させた液を皮膚機能賦活化粧料組成物として用いることを特徴とする。すなわち請求項1にかかわる発明は、ヤエヤマアオキ熟成果実発酵液からなる皮膚機能賦活化粧料組成物に関し、請求項2に関わる発明は、賦活する皮膚機能が表皮過角化抑制能である請求項1のヤエヤマアオキ熟成果実発酵液からなる皮膚機能賦活化粧料組成物に関する。  The present invention is characterized by using a liquid obtained by ripening and further fermenting Yaeyama Aoki fruit as a skin function activating cosmetic composition. That is, the invention according to claim 1 relates to a skin function-activating cosmetic composition comprising a fermented liquor ripening fruit actual fermented liquid, and the invention according to claim 2 is that the skin function to be activated is an ability to suppress hyperkeratosis of the epidermis. The present invention relates to a skin function activating cosmetic composition comprising a fermented liquor of Yaeyama Aoki.

本発明のヤエヤマアオキ熟成果実発酵液からなる皮膚機能賦活化粧料組成物は、その配合化粧料使用において表皮の過角化を改善して皮膚のこじわ増を抑え、チロシナーゼ活化を阻んで皮膚の美白に働き、コラゲナーゼ活化を妨げて皮膚柔軟性維持を助けるなど、皮膚機能賦活にすぐれた効果をみせることができる。The skin function activating cosmetic composition comprising the real fermented liquor of Yaeyama Aoki according to the present invention improves skin hyperkeratinization and suppresses skin wrinkle increase and prevents tyrosinase activation by using the blended cosmetic. It has an excellent effect on skin function activation, such as preventing collagenase activation and helping to maintain skin flexibility.

本発明において用いるヤエヤマアオキ果実成分は、熟成果実を十分発酵させて得たろ液である。この形態において、ヤエヤマアオキ果実成分は、その抽出物、粉砕物、圧搾物に比べ、低分子化されて機能発現が大になる。The Yaeyama Aoki fruit component used in the present invention is a filtrate obtained by sufficiently fermenting the fruits of ripeness. In this form, the Yaeyama Aoki fruit component has a lower molecular weight and a greater function expression than its extract, pulverized product, and pressed product.

本発明において用いられるヤエヤマアオキ熟成果実発酵液は、アカネ科植物であるヤエヤマアオキ(Morinda citrifolia)の果実を熟成させ発酵させて得る。すなわちヤエヤマアオキの果実をそれが白黄色(淡黄色)に熟するをまって収穫し、常水(精製水)で洗浄し貯蔵タンク中に入れて密封する。そのまま約4〜6週間追熟させ自然発酵させる。その後、タンクを開栓し発酵液をろ過し公知の方法で滅菌する。(但し好ましくは低温殺菌の方法を採る。)  The ripening fruit real fermented liquor used in the present invention is obtained by aging and fermenting the fruit of Morae citrifolia, which is a Rubiaceae plant. That is, the fruit of Yaeyama Aoki is harvested by ripening it to white yellow (pale yellow), washed with normal water (purified water), put in a storage tank and sealed. Continue ripening for about 4-6 weeks and ferment naturally. Thereafter, the tank is opened, the fermentation broth is filtered and sterilized by a known method. (However, a pasteurization method is preferably used.)

かくして得られたヤエヤマアオキ熟成果実発酵液には通常の化粧品医薬部外品に用いられる各種成分を特に限定せずに配合できる。各種成分として、ワックス類、多価アルコール類、炭化水素、油脂類、脂肪酸類、アルコール類、エステル類、アミン・アミド・金属石鹸類、ガム質及び水溶性高分子化合物、界面活性剤、酸化防止剤、防腐殺菌剤、ビタミン類、アミノ酸類、有機無機の薬品類、生薬抽出物ほかの保湿剤、金属封鎖剤、色材類、香料、石鹸素地等をあげることができる。またこれら各種成分の化粧料等への配合量には特に限定はなく、目的化粧料の用途により適宜調整すればよい。  Various components used in ordinary cosmetic quasi-drugs can be blended in the fermented real yam ripening fruits obtained in this way without particular limitation. As various components, waxes, polyhydric alcohols, hydrocarbons, fats and oils, fatty acids, alcohols, esters, amines, amides, metal soaps, gums and water-soluble polymer compounds, surfactants, antioxidants Examples include agents, antiseptics, vitamins, amino acids, organic and inorganic chemicals, herbal extracts and other moisturizers, metal sequestering agents, coloring materials, fragrances, soap bases, and the like. Moreover, there is no limitation in particular in the compounding quantity of these various components to cosmetics etc., What is necessary is just to adjust suitably according to the use of the target cosmetics.

ヤエヤマアオキ熟成果実発酵液の配合量にも特に限定のあるものでなく、0.1〜100(重量)%の間であれば可とするが、目的化粧料の用途によって1〜20(重量)%の配合をもっとも好ましくする。  There is no particular limitation on the blending amount of the real fermented liquor of Yaeyama Aoki, and it may be between 0.1 and 100 (weight)%, but it may be between 1 and 20 (weight)% depending on the intended cosmetic use. Is most preferable.

本発明にかかわるヤエヤマアオキ熟成果実発酵液の化粧料への利用形態も、特に限定されるものでなく、例えばクリーム、ローション、乳液、パック類、シャンプー、リンス、ヘアトニック、育毛剤、石鹸などを例示することができる。  The form of use of the fermented liquor fruit fermented fruit according to the present invention is not particularly limited, and examples include creams, lotions, emulsions, packs, shampoos, rinses, hair tonics, hair restorers, soaps, etc. can do.

本発明でいう表皮過角化抑制について説明すると、皮膚の過角化とはいわゆる美肌を損なう最大要因であって皮膚の老化と同義であるが、表皮基底層でつくられた細胞が角化しても角解が捗らず堆積し硬くなる有様をいい、皮溝を深くし、皮膚の乾燥やしわの原因となることである。表皮細胞の過角化(硬くなること)は、みずみずしさを保つための皮膚水分の疎通を妨げるし、表皮細胞で紫外線を吸収したメラニン色素の角解による排出を滞らせて肌を黒くしたりもする。このことにより表皮過角化の抑制は、皮膚機能賦活のポイントであるともいえる。Explaining the suppression of hyperkeratinization in the present invention, the hyperkeratinization of the skin is the largest factor that damages so-called beautiful skin and is synonymous with aging of the skin, but the cells made in the epidermal basal layer are keratinized. However, it means that the keratophyte does not progress and accumulates and hardens, deepens the skin groove, and causes dry skin and wrinkles. Hyperkeratinization (hardening) of the epidermal cells prevents the skin moisture from passing through to maintain freshness, delays the excretion of the melanin pigment that has absorbed ultraviolet rays in the epidermal cells, and causes the skin to darken. Also do. Thus, it can be said that suppression of hyperkeratosis is a point of skin function activation.

次に本発明でいうチロシナーゼ抑制についてであるが、チロシナーゼ(ty−rosinase)とはジフエノールオキシダーゼまたはカテコールオキシダーゼのことで、メラノサイトの顆粒(メラノソーム)中なる酵素である。すなわちチロシンを酸化して、皮膚においては過剰の光を吸収するメラニンをつくる。メラニンの過産生は、いうまでもなく、皮膚の色を黒くし、しみのあらわれにつながるが、チロシナーゼの働きは、紫外線の刺激ほか、ストレスによっても活発になる。ストレスによるヒスタミンなど神経伝達物質の生成増がチロシナーゼの働きを介してメラニン過産生につながるわけである。近時の生活環境がストレスをさらに加速するものであることはいうまでもない。  Next, tyrosinase inhibition referred to in the present invention is tyrosinase (di-phenol oxidase or catechol oxidase), which is an enzyme in melanocyte granules (melanosomes). That is, it oxidizes tyrosine to produce melanin that absorbs excess light in the skin. Needless to say, overproduction of melanin darkens the color of the skin and leads to the appearance of stains, but the action of tyrosinase is activated not only by the stimulation of ultraviolet rays but also by stress. Increased production of neurotransmitters such as histamine due to stress leads to melanin overproduction through the action of tyrosinase. Needless to say, the recent living environment further accelerates stress.

次いで本発明にいうコラゲナーゼ抑制についていうと、コラゲナーゼ(co−llagenaze)とは、からだの組織間、細胞間の結合、支持(構造を支える)にあたる結合組織構成タン白であるコラーゲンを切断するプロテアーゼである。皮膚におけるコラーゲンは、エラスチンと共に皮膚弾力線維を編んで、皮膚柔軟性をつくる。コラーゲンを壊すコラゲナーゼは、生活環境の劣化によっても容易に活性化し、皮膚におけるその活性化は、紫外線、汚染大気、タバコの副流煙などによってもたらされる。  Next, with respect to collagenase inhibition according to the present invention, collagenase is a protease that cleaves collagen, which is a connective tissue constituent protein that serves as a bond and support (supports structure) between body tissues and cells. is there. Collagen in the skin creates skin flexibility by weaving skin elastic fibers together with elastin. Collagenase that breaks down collagen is easily activated by deterioration of the living environment, and its activation in the skin is brought about by ultraviolet rays, polluted air, sidestream smoke of tobacco, and the like.

上記のようにして得られる本発明の皮膚機能賦活化粧料組成物は、表皮の過角化、チロシナーゼ、コラゲナーゼなどを抑制し皮膚機能劣化のあらわれであるこじわやしみ、皮膚柔軟性低下などをよく予防改善する。  The skin function activating cosmetic composition of the present invention obtained as described above suppresses hyperkeratinization of the epidermis, tyrosinase, collagenase, etc. Well preventive improvement.

以下、本発明の皮膚機能賦活化粧料組成物を、実施例に基づき説明するが、本発明はこれら実施例に限定されるものではない。
(実施例1)〜ヤエヤマアオキ熟成果実発酵液の調整、ヤエヤマアオキ(アカネ科)の熟成させた果実をよく水洗し、内容量1.5トンの貯蔵タンク中に封入し、密封して6週間置き発酵させる。その後、タンクのバルブを開いてフィルターにかけつつ流出させて取り出し、流出液を低温殺菌し所望の発酵液を得る。
Hereinafter, although the skin function activation cosmetic composition of this invention is demonstrated based on an Example, this invention is not limited to these Examples.
(Example 1) ~ Adjustment of real fermented liquor of Yaeyama Aoki, matured fruit of Yaeyama Aoki (Rubiaceae), thoroughly washed with water, sealed in a 1.5-ton storage tank, sealed and fermented for 6 weeks Let After that, the tank valve is opened and drained while being filtered, and the effluent is pasteurized to obtain a desired fermentation broth.

(実施例2):クリームの調整〜以下の組成でクリームをつくる。
ステアリン酸 10.0
セタノール 2.0
ラノリン 1.0
ミリスチン酸イソプロピル 3.0
モノステアリン酸ポリエチレングリコール 1.5
トリエタノールアミン 0.8
ソルビトール 4.0
パラベン 0.1
実施例1のヤエヤマアオキ熟成果実発酵液 1.0
香料 0.1
精製水 残部
合計 100.0(重量%)
(Example 2): Preparation of cream-A cream is prepared with the following composition.
Stearic acid 10.0
Cetanol 2.0
Lanolin 1.0
Isopropyl myristate 3.0
Polyethylene glycol monostearate 1.5
Triethanolamine 0.8
Sorbitol 4.0
Paraben 0.1
Yaeyama Aoki maturity fruit fermentation liquid of Example 1 1.0
Fragrance 0.1
Purified water balance <br/> Total 100.0 (% by weight)

(試験例1):過角化改善の試験
乾燥肌であることを自認及び他認を重ねて確かめた女性(45才〜55才)12人を任意に6人ずつのA.B二群に分け、何れも両前腕内側同位置の1.5cm四方大に市販蛍光マーカー(油性)を塗擦、次いで12時間後同位置に再塗擦する。次日から就寝前に、A群は右腕蛍光マーカー塗擦部位に実施例2のクリームを塗り、起床時水洗し、就寝時塗布することを繰り返した。B群は実施例2のクリームから実施例1発酵液を除いて調整したクリームを、A群と同じ方法で塗布を続け対象例とした。各左腕比右腕蛍光マーカー消失確認までの日数を測り、B群6人における平均日数比A群各人それぞれの消失確認日数が10%以上短縮あったときこれを有効とし、5%以上の短縮をやや有効、それ以下を無効とした。結果を表1に示す。
(Test Example 1): Test for improvement of hyperkeratosis 12 women (45 to 55 years old) who have confirmed and confirmed themselves that they have dry skin. B divided into two groups, and in both cases, a commercially available fluorescent marker (oil-based) is applied to 1.5 cm square size at the same position inside both forearms, and then re-coated at the same position after 12 hours. From the next day before bedtime, Group A repeatedly applied the cream of Example 2 on the site where the right arm fluorescent marker was applied, washed with water when waking up, and applied at bedtime. In Group B, the cream prepared by removing the fermented liquid of Example 1 from the cream of Example 2 was continuously applied in the same manner as in Group A, and used as a target example. Measure the number of days until the confirmation of disappearance of the right arm fluorescent marker for each left arm ratio. The average number of days ratio in group B 6 persons When the disappearance confirmation days for each person in group A is shortened by 10% or more, this is effective. Somewhat valid, less than that is invalid. The results are shown in Table 1.

Figure 2005145945
Figure 2005145945

(試験例2):チロシナーゼ抑制試験
ヤエヤマアオキ熟成果実発酵液(実施例1)のチロシナーゼ阻害活性をS−himano氏の方法によるドーパクロムの定量法を用いて行った。すなわち試薬としてL−Tyrosine(1mg/1ml)、チロシナーゼ(Sigma製、1mg=4000U/ml)、リン酸緩衝液(pH6.8、0.1M)、検液(ハイドロキノン液〜0.1%、0.01%、0.001%、0.0001%)、蒸留水を用意して所定の操作を行い、475nm、480nmでの吸光度を測って検量線をつくり、実施例1の発酵液(0.1%)の475nmにおける吸光度を測り、検量線によって、スタンダードを0としたときのチロシナーゼ活性抑制能をハイドロキノン相当量としてみたものである。
結果〜実施例1の発酵液のチロシナーゼ活性抑制能>ハイドロキノン0.01%のチロシナーゼ活性抑制能。
(Test Example 2): Tyrosinase Inhibition Test The tyrosinase inhibitory activity of the real fermented liquor (Yamayama Aoki) ripening result (Example 1) was carried out using a method for determining dopachrome by the method of Mr. S-himano. That is, L-Tyrosine (1 mg / 1 ml), tyrosinase (manufactured by Sigma, 1 mg = 4000 U / ml), phosphate buffer solution (pH 6.8, 0.1 M), test solution (hydroquinone solution to 0.1%, 0 .01%, 0.001%, 0.0001%) and distilled water are prepared and subjected to a predetermined operation. The absorbance at 475 nm and 480 nm is measured to create a calibration curve. 1%) at 475 nm, and the tyrosinase activity-inhibiting ability when the standard is 0 is taken as a hydroquinone equivalent amount by a calibration curve.
Results-Tyrosinase activity inhibitory ability of fermentation broth of Example 1> Hydroquinone 0.01% tyrosinase activity inhibitory ability.

(試験例3)〜実施例1のヤエヤマアオキ熟成果実発酵液のコラゲナーゼ活性阻害作用の測定を、Wunsch−Heidrich法の一部改変法(生薬学雑誌、42、249(1998))により行った。すなわち、酵素溶液はコラゲナーゼN−2 from Streptomyces parvulas sub−sp.citrnus(新田ゼラチン製)を0.1mg/mlに、基質溶液はpZ−petide(4−phenylazobenzyloxycarbonyl−Pro−Leu−Gly−D−Arg・HO、Bachem feinc−hemikalien AG製)を0.5mg/mlに、それぞれ0.1Mt−ris緩衝液(pH7.1、20mMCacl含有)を用いて調製した。
実施例1の発酵液0.06mlに酵素溶液0.05mlと基質溶液0.4mlを加え、37℃で30分反応させ、0.5mMクエン酸溶液1mlを加えて反応をとどめ、酢酸エチル5mlを加えて抽出し、遠心分離してのち、酢酸エチルを対照に、320nmにおける酢酸エチル層の吸光度「T」を測定した。酵素溶液の代りに水を用いたものをブランク「B」、実施例1のサンプルの代りに水を用いたものをコントロール「C」とした。
コラゲナーゼ活性阻害率(%)=100×{1−(「T」−「B」)/「C」−「B」}による。実施例1の発酵液のコラゲナーゼ活性阻害率は79%であった。
(Test Example 3)-The measurement of the collagenase activity inhibitory action of the real fermented liquor of Yaeyama Aoki in Example 1 was carried out by a partial modification of the Wunsch-Heidrich method (Biopharmaceutical Journal, 42, 249 (1998)). That is, the enzyme solution was collagenase N-2 from Streptomyces parvulas sub-sp. citronus (made by Nitta Gelatin) at 0.1 mg / ml, and the substrate solution by pZ-petide (4-phenylazobenzoylcarbonyl-Pro-Leu-Gly-D-Arg.H 2 O, Bachem feinc-hemikalian AG). 5 mg / ml was prepared using 0.1 Mt-ris buffer (pH 7.1, containing 20 mM Cacl 2 ).
Add 0.05 ml of enzyme solution and 0.4 ml of substrate solution to 0.06 ml of fermented liquid of Example 1, react at 37 ° C. for 30 minutes, stop the reaction by adding 1 ml of 0.5 mM citric acid solution, and add 5 ml of ethyl acetate. In addition, after extracting and centrifuging, the absorbance “T” of the ethyl acetate layer at 320 nm was measured using ethyl acetate as a control. A blank “B” was obtained using water instead of the enzyme solution, and a control “C” was obtained using water instead of the sample of Example 1.
Collagenase activity inhibition rate (%) = 100 × {1 − (“T” − “B”) / “C” − “B”}. The collagenase activity inhibition rate of the fermentation broth of Example 1 was 79%.

(実施例3)石鹸
実施例1のヤエヤマアオキ熟成発酵液 2.5
ヤシ油脂肪酸 18.0
パーム油脂肪酸 20.0
グリセリン 14.0
水酸化カリウム 5.0
トリエタノールアミン 25.0
蒸留水 残部
合計 100.0(重量%)
(対照例1)
実施例3の石鹸処方中の実施例1のヤエヤマアオキ熟成果実発酵液を除きその代りにヤエヤマアオキ果実圧搾液を5.0重量%配合した処方で作った石鹸。
(対照例2)
対照例1の石鹸処方中からヤエヤマアオキ果実圧搾液を除いた処方で作った石鹸。
(Example 3) Soybean Aoki ripening fermented liquid of Example 1 2.5
Palm oil fatty acid 18.0
Palm oil fatty acid 20.0
Glycerol 14.0
Potassium hydroxide 5.0
Triethanolamine 25.0
Distilled water balance <br/> Total 100.0 (% by weight)
(Control 1)
The soap made by blending 5.0% by weight of the Yamae Aoki fruit pressurizing solution instead of the fermented real yak Yamaoki fruit of Example 1 in the soap formulation of Example 3.
(Control 2)
A soap made from the soap formulation of Control Example 1 without the Yaeyama Aoki fruit pressurizing solution.

17〜61才の女性11人に、(対照例2)、(対照例1)、(実施例3)の石鹸を試料とし一日一試料ずつ三日間に分けて用い入浴時洗顔してもらい、用後の状態を調べた。結果を(表2)に示す。Eleven women aged 17 to 61 years old have the soaps of (Control 2), (Control 1), and (Example 3) as samples and wash each face for 3 days, and wash the face when taking a bath. The condition after use was examined. The results are shown in (Table 2).

Figure 2005145945
Figure 2005145945

Claims (2)

ヤエヤマアオキ熟成果実発酵液からなる皮膚機能賦活化粧料組成物。  A skin function-activating cosmetic composition comprising a fermented liquor of Yaeyama Aoki. 賦活する皮膚機能が表皮過角化抑制機能である請求項1の皮膚機能賦活化粧料組成物。  The skin function activating cosmetic composition according to claim 1, wherein the skin function to be activated is an epikeratosis suppression function.
JP2003418679A 2003-11-14 2003-11-14 Skin function-activating cosmetic composition Pending JP2005145945A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003418679A JP2005145945A (en) 2003-11-14 2003-11-14 Skin function-activating cosmetic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003418679A JP2005145945A (en) 2003-11-14 2003-11-14 Skin function-activating cosmetic composition

Publications (1)

Publication Number Publication Date
JP2005145945A true JP2005145945A (en) 2005-06-09

Family

ID=34697113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003418679A Pending JP2005145945A (en) 2003-11-14 2003-11-14 Skin function-activating cosmetic composition

Country Status (1)

Country Link
JP (1) JP2005145945A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030000A1 (en) * 2008-09-12 2010-03-18 学校法人 日本大学 Skin-whitening agent and external skin preparation for whitening of skin
JP2010090093A (en) * 2008-10-10 2010-04-22 Maruzen Pharmaceut Co Ltd Type i collagen production promotor, filaggrin production promoter, involucrin production promoter, and transglutaminase 1 production promoter
KR101093863B1 (en) 2009-03-11 2011-12-13 주식회사 한국화장품제조 A cosmetic composition comprising an extract of the tissue cultured morinda citirifolia callus extracts and a preparation method of the extract
KR101352823B1 (en) * 2013-04-03 2014-01-17 (주)코스메랩 A method for preparing functional of extract morinda citrifolia, noni and the composition comprising the same having potent skin-protecting activity and showing potent treating or preventing skin aging
KR101768026B1 (en) 2015-07-08 2017-08-14 주식회사 코리아나화장품 Cosmetic Composition for Improving Skin Wrinkle Comprising the Fermented Extract of Morinda citrifolia as Active Ingredient
JP6389308B1 (en) * 2017-08-23 2018-09-12 一丸ファルコス株式会社 Topical skin preparation
CN111514072A (en) * 2020-05-17 2020-08-11 海南师范大学 Millettia speciosa-noni composite enzyme, preparation method thereof and application of millettia speciosa-noni composite enzyme in preparation of facial mask

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030000A1 (en) * 2008-09-12 2010-03-18 学校法人 日本大学 Skin-whitening agent and external skin preparation for whitening of skin
JP2010090093A (en) * 2008-10-10 2010-04-22 Maruzen Pharmaceut Co Ltd Type i collagen production promotor, filaggrin production promoter, involucrin production promoter, and transglutaminase 1 production promoter
KR101093863B1 (en) 2009-03-11 2011-12-13 주식회사 한국화장품제조 A cosmetic composition comprising an extract of the tissue cultured morinda citirifolia callus extracts and a preparation method of the extract
KR101352823B1 (en) * 2013-04-03 2014-01-17 (주)코스메랩 A method for preparing functional of extract morinda citrifolia, noni and the composition comprising the same having potent skin-protecting activity and showing potent treating or preventing skin aging
WO2014163298A1 (en) * 2013-04-03 2014-10-09 (주)코스메랩 Extraction method for separating noni residue extract exhibiting strong skin protection effect and composition containing same for protecting skin and for treating and preventing skin aging
KR101768026B1 (en) 2015-07-08 2017-08-14 주식회사 코리아나화장품 Cosmetic Composition for Improving Skin Wrinkle Comprising the Fermented Extract of Morinda citrifolia as Active Ingredient
JP6389308B1 (en) * 2017-08-23 2018-09-12 一丸ファルコス株式会社 Topical skin preparation
JP2019038754A (en) * 2017-08-23 2019-03-14 一丸ファルコス株式会社 Skin external preparation
CN111514072A (en) * 2020-05-17 2020-08-11 海南师范大学 Millettia speciosa-noni composite enzyme, preparation method thereof and application of millettia speciosa-noni composite enzyme in preparation of facial mask
CN111514072B (en) * 2020-05-17 2022-10-21 海南师范大学 Millettia speciosa-noni composite enzyme, preparation method thereof and application of millettia speciosa-noni composite enzyme in preparation of facial mask

Similar Documents

Publication Publication Date Title
JP4927718B2 (en) Blackberry extract
JP2002193738A (en) Use of at least one extract from at least one azalea plant in composition for treating symptom of skin aging
JP2013502380A (en) Skin refining complex, use of said complex, cosmetic or pharmaceutical composition comprising said complex and method for its application
US8557795B2 (en) Composition containing Chamaecyparis obtusa polysaccharides to be externally applied to the skin
KR101601022B1 (en) Composition of skin external application containing ginseng flower essential oil
KR20140003198A (en) Composition of skin external application containing compound k
JP2003081749A (en) Skin care preparation
FR2755367A1 (en) USE OF AN ERECTA POTENTIAL EXTRACT IN THE FIELD OF COSMETICS AND PHARMACY, ESPECIALLY DERMATOLOGY
JP2010511021A (en) Use of gamma aminobutyric acid as a depigmenting agent.
US10149817B2 (en) Topical skin treatment composition comprising dendranthema indicum extract
KR101858464B1 (en) Cosmetic compositions containing Desmodii Herba extaracts for prevention of skin aging and improvement of skin wrinkle
KR101716428B1 (en) Cosmetic composition containing fermentative extract of hippocampus coronatus as active ingredient
JP2005145945A (en) Skin function-activating cosmetic composition
KR20170076147A (en) Composition for improving skin
JP2000344655A (en) Skin cosmetic
CN104470488B (en) Expression modulation compositions of DICKKOPF 1 and application thereof
KR101775485B1 (en) Cosmetic composition containing fermentative extract of Spatholobus suberectus Dunn as active ingredient
JP2011195539A (en) Elastase activity inhibitor
JP2000072653A (en) Use of fatty acid for cosmetic
WO2008044636A1 (en) Anti-wrinkle agent and skin preparation for external use
JP2008255043A (en) Skincare preparation for external use
JP2000319122A (en) Cell proliferation promoting cosmetic
CN111166688A (en) Application of arteannuin in cosmetics as moisture-keeping, wrinkle-resisting and anti-aging component
KR102257089B1 (en) Cosmetic composition for moisturizing comprising diphylleia grayi extract
KR101460672B1 (en) Composition for preventing hair damage containing the extract of mycoleptodonoides aitchisonii fruit body